Our recent discovery of a novel human lncRNA, which we initially identified as a suppressor of the KAI1/CD82 in triple-negative breast cancer11, confronted us with the question of how to stimulate the epigenetically suppressed activity of KAI1 in metastatic cancer(s). This evidence concerns the gene CD82 and metastatic malignant neoplasm.